Back to mobile site

More on NSRX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (9/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NY:NSRX)
Delayed: 3.44 +0.01 (0.29%)
Prev. Close $3.43  
Open$3.44 
52 Wk High$ 
52 Wk Low$ 
Day High$3.44 
Day Low$3.44 
P/E N/A  
EPS$ 
Volume1,400 


Jun 23, 2026 08:35 AM Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
Jun 22, 2026 08:00 AM Nasus Pharma to Participate in the Zacks Life Sciences Investor Forum
Jun 22, 2026 07:13 AM Form 4 Nasus Pharma Ltd For: Jun 17 Filed by: Teleman Dan Benjamin
Jun 11, 2026 05:15 AM Nasus Pharma (NSRX) Reiterated at Market Outperform by Citizens
Jun 9, 2026 04:07 PM Form 6-K Nasus Pharma Ltd For: Jun 09
Jun 9, 2026 08:01 AM Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron
Jun 9, 2026 08:00 AM Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003) 
Jun 1, 2026 08:00 AM Nasus Pharma to Host Virtual KOL Event on June 10, 2026 to Discuss NS002 for the Treatment of Anaphylaxis
May 26, 2026 05:20 PM Form S-8 Nasus Pharma Ltd
May 15, 2026 06:36 AM Form SCHEDULE 13G Nasus Pharma Ltd Filed by: BALYASNY ASSET MANAGEMENT L.P.
View All Articles

Entities mentioned with NSRX

View All Entities